Breast cancer has emerged as the most prevalent malignant neoplasm worldwide, with over 90% of breast cancer patients diagnosed with early-stage disease, among which the most common subtype is hormone receptor (HR)-positive (Cardoso et al., 2018). This evidence concerns the gene NR4A1 and breast cancer.